Pediatric Study Planning With FDA, EMA To Be More Closely Aligned

Beginning in January, FDA will require initial pediatric study plans be submitted after the end-of-Phase II meeting, rather than well into Phase III, which is expected to improve planning and expand coordination with EMA.